89
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Evaluation of Local Side Effects of Captopril Gel in the Rabbit Model

, , , , , , & show all
Pages 197-199 | Received 06 Jun 2006, Accepted 01 Mar 2007, Published online: 11 Nov 2011
 

Abstract

Shirazi, M., Hassanpour, A., Khezri, A., Samani, S.M., Monabbati, A., Tanideh, N., Bahri, M.A. and Mehrabani, D. 2007. Evaluation of local side effects of captopril gel in the rabbit model. J. Appl. Anim. Res., 31: 197–199.

To evaluate the safety of using captopril gel as an antifibrotic agent for preventing recurrence of urethral stricture after a direct vision internal urethrotomy, twelve rabbits were divided into three equal groups, and three types of gel were instilled into the urethra using a lubricating gel as placebo (group I), 0.1% captopril gel (group II), and 2.5% captopril gel (group III). One more rabbit served as control. Changes in the urethral mucosa were evaluated at the end of one week and three months. Mild ulceration and denudation of proximal and distal urothelium were seen with secondary aggregation of inflammatory cells beneath the lamina propria in the early phase in all three groups. No inflammation, scarring, or other side effects were seen in the late phase. As the local side effects of captopril gel on the urothelium were not significant its application in human urethral stricture is recommended.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.